These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 25494811)

  • 1. Nocebo effects and psychotropic drug action.
    Amanzio M
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):159-61. PubMed ID: 25494811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events, placebo and nocebo effects in placebo-treated paediatric patients with refractory focal epilepsies. Analysis of double-blind studies.
    Zaccara G; Giovannelli F; Franco V; Cincotta M; Tramacere L; Verrotti A
    Epilepsy Res; 2014 Dec; 108(10):1685-93. PubMed ID: 25288026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocebo effects in the treatment of major depression: results from an individual study participant-level meta-analysis of the placebo arm of duloxetine clinical trials.
    Dodd S; Schacht A; Kelin K; Dueñas H; Reed VA; Williams LJ; Quirk FH; Malhi GS; Berk M
    J Clin Psychiatry; 2015 Jun; 76(6):702-11. PubMed ID: 26132671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocebo Responses in Brain Diseases: A Systematic Review of the Current Literature.
    Zis P; Mitsikostas DD
    Int Rev Neurobiol; 2018; 139():443-462. PubMed ID: 30146057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocebo in clinical trials for depression: a meta-analysis.
    Mitsikostas DD; Mantonakis L; Chalarakis N
    Psychiatry Res; 2014 Jan; 215(1):82-6. PubMed ID: 24210741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials.
    Howick J; Webster R; Kirby N; Hood K
    Trials; 2018 Dec; 19(1):674. PubMed ID: 30526685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice.
    Mitsikostas DD; Chalarakis NG; Mantonakis LI; Delicha EM; Sfikakis PP
    Eur J Neurol; 2012 May; 19(5):672-80. PubMed ID: 21973313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials.
    Zis P; Mitsikostas DD
    J Neurol Sci; 2015 Aug; 355(1-2):94-100. PubMed ID: 26073486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocebo effects and psychotropic drug action - an update.
    Amanzio M; Palermo S
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):75-77. PubMed ID: 31995411
    [No Abstract]   [Full Text] [Related]  

  • 10. Nocebo in cerebellar ataxia: A systematic review and meta-analysis of placebo-controlled clinical trials.
    Alam JM; Hadjivassiliou M; Zis P
    J Neurol Sci; 2019 Jun; 401():112-117. PubMed ID: 31075682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between placebo arm inclusion and adverse event rates in antidepressant randomized controlled trials: An examination of the Nocebo Effect.
    Cheung CP; Thiyagarajah MT; Abraha HY; Liu CS; Lanctôt KL; Kiss AJ; Saleem M; Juda A; Levitt AJ; Schaffer A; Cheung AH; Sinyor M
    J Affect Disord; 2021 Feb; 280(Pt A):140-147. PubMed ID: 33212405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocebo vs. placebo: the challenges of trial design in analgesia research.
    Vase L; Amanzio M; Price DD
    Clin Pharmacol Ther; 2015 Feb; 97(2):143-50. PubMed ID: 25670519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-placebo differences for specific adverse events in major depressive disorder: A systematic review.
    Sinyor M; Cheung CP; Abraha HY; Lanctôt KL; Saleem M; Liu CS; Li A; Juda A; Levitt AJ; Cheung AH; Schaffer A
    J Affect Disord; 2020 Apr; 267():185-190. PubMed ID: 32217218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review.
    Häuser W; Bartram C; Bartram-Wunn E; Tölle T
    Clin J Pain; 2012 Jun; 28(5):437-51. PubMed ID: 22336767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocebo response in Parkinson's disease: A systematic review and meta-analysis.
    Leal Rato M; Duarte GS; Ferreira AN; Alves M; Mainoli B; Teodoro T; Mestre TA; Costa J; Ferreira JJ
    Parkinsonism Relat Disord; 2019 Aug; 65():13-19. PubMed ID: 31103487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocebo in chronic inflammatory demyelinating polyneuropathy; a systematic review and meta-analysis of placebo-controlled clinical trials.
    Zis P; Hadjivassiliou M; Sarrigiannis PG; Jenkins TM; Mitsikostas DD
    J Neurol Sci; 2018 May; 388():79-83. PubMed ID: 29627036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo-controlled clinical trials.
    Mahr A; Golmard C; Pham E; Iordache L; Deville L; Faure P
    Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):731-741. PubMed ID: 28176407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocebo effect in myasthenia gravis: systematic review and meta-analysis of placebo-controlled clinical trials.
    Varma A; Zis P
    Acta Neurol Belg; 2019 Jun; 119(2):257-264. PubMed ID: 31004288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo and nocebo responses in randomized controlled trials of Janus kinase inhibitor monotherapy for rheumatoid arthritis : A meta-analysis.
    Sung YK; Lee YH
    Z Rheumatol; 2022 Jun; 81(5):430-437. PubMed ID: 33687525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo and nocebo effects in the neurological practice.
    Bittar C; Nascimento OJ
    Arq Neuropsiquiatr; 2015 Jan; 73(1):58-63. PubMed ID: 25608129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.